• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The Quest for Relevant Hepatocellular Carcinoma Biomarkers.寻找相关的肝细胞癌生物标志物。
Cell Mol Gastroenterol Hepatol. 2017 Jul 14;4(2):283-284. doi: 10.1016/j.jcmgh.2017.06.003. eCollection 2017 Sep.
2
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.与肝细胞癌相关的血清蛋白生物标志物及其检测
Analyst. 2016 Jan 7;141(1):36-44. doi: 10.1039/c5an01884f. Epub 2015 Nov 25.
3
[Bioinformatics on vascular invasion markers in hepatocellular carcinoma via Big-Data analysis].通过大数据分析对肝细胞癌血管侵袭标志物进行生物信息学研究
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Apr 10;38(4):522-527. doi: 10.3760/cma.j.issn.0254-6450.2017.04.022.
4
Genomic and proteomic biomarkers for diagnosis and prognosis of hepatocellular carcinoma.用于肝细胞癌诊断和预后的基因组和蛋白质组生物标志物。
Biomark Med. 2007 Aug;1(2):273-84. doi: 10.2217/17520363.1.2.273.
5
Prognostic value of PIVKA-II in hepatocellular carcinoma patients receiving curative ablation: A systematic review and meta-analysis.PIVKA-II在接受根治性消融的肝细胞癌患者中的预后价值：一项系统评价和荟萃分析
Int J Biol Markers. 2018 Aug;33(3):266-274. doi: 10.1177/1724600818760234. Epub 2018 Apr 16.
6
Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌的循环预测性和诊断性生物标志物
World J Gastroenterol. 2016 Oct 7;22(37):8271-8282. doi: 10.3748/wjg.v22.i37.8271.
7
Is there an ideal prognostic classification for hepatocellular carcinoma? The quest for the Holy Grail.肝细胞癌是否存在理想的预后分类？对圣杯的探寻。
J Hepatol. 2010 Jul;53(1):23-4. doi: 10.1016/j.jhep.2010.04.002. Epub 2010 Apr 18.
8
Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma.miRNA-221 表达失调与手术切除的肝细胞癌患者预后相关的生物标志物。
Hum Pathol. 2011 Oct;42(10):1391-400. doi: 10.1016/j.humpath.2010.12.010. Epub 2011 Apr 1.
9
The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.寻找适合进行肝细胞癌移植的患者的探索仍在继续：从米兰到旧金山，再到多伦多，乃至更远。
Hepatology. 2016 Dec;64(6):1853-1855. doi: 10.1002/hep.28841. Epub 2016 Oct 25.
10
Hepatocellular carcinoma tumour markers: current role and expectations.肝细胞癌肿瘤标志物：当前作用与期望
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):843-53. doi: 10.1016/j.bpg.2014.07.018. Epub 2014 Aug 22.

引用本文的文献

1
The regulatory role of LncRNA HCG18 in various cancers.LncRNA HCG18 在多种癌症中的调控作用。
J Mol Med (Berl). 2023 Apr;101(4):351-360. doi: 10.1007/s00109-023-02297-5. Epub 2023 Mar 6.
2
Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.线粒体相关转录组特征与肝细胞癌的预后、血管侵犯、肿瘤微环境和治疗反应相关。
Oxid Med Cell Longev. 2022 Apr 30;2022:1592905. doi: 10.1155/2022/1592905. eCollection 2022.
3
HCG18 Participates in Vascular Invasion of Hepatocellular Carcinoma by Regulating Macrophages and Tumor Stem Cells.人绒毛膜促性腺激素18通过调节巨噬细胞和肿瘤干细胞参与肝细胞癌的血管侵袭。
Front Cell Dev Biol. 2021 Aug 30;9:707073. doi: 10.3389/fcell.2021.707073. eCollection 2021.
4
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers.肝癌血管侵犯的基因组分析揭示了分子驱动因素和预测性生物标志物。
Hepatology. 2021 Jun;73(6):2342-2360. doi: 10.1002/hep.31614. Epub 2021 May 8.
5
Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model.在一个转化性非酒精性脂肪性肝炎（NASH）小鼠模型中揭示与NASH相关纤维化发病的预测性分子特征。
Cell Mol Gastroenterol Hepatol. 2017 Oct 14;5(1):83-98.e10. doi: 10.1016/j.jcmgh.2017.10.001. eCollection 2018.

本文引用的文献

1
Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma.人类肝细胞癌中持续改变的代谢靶点的鉴定
Cell Mol Gastroenterol Hepatol. 2017 May 31;4(2):303-323.e1. doi: 10.1016/j.jcmgh.2017.05.004. eCollection 2017 Sep.
2
Hepatocellular carcinoma: Review of disease and tumor biomarkers.肝细胞癌：疾病与肿瘤生物标志物综述
World J Hepatol. 2016 Apr 8;8(10):471-84. doi: 10.4254/wjh.v8.i10.471.
3
A statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC study.一种使用代谢组学数据对中间相遇原则进行建模的统计框架：在EPIC研究中应用于肝细胞癌。
Mutagenesis. 2015 Nov;30(6):743-53. doi: 10.1093/mutage/gev045. Epub 2015 Jun 30.
4
Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-alcoholic fatty liver disease.肝细胞的基因组规模代谢建模揭示非酒精性脂肪性肝病患者的丝氨酸缺乏。
Nat Commun. 2014;5:3083. doi: 10.1038/ncomms4083.
5
Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.应用非靶向组织代谢组学对肝细胞癌进行代谢特征分析。
Cancer Res. 2013 Aug 15;73(16):4992-5002. doi: 10.1158/0008-5472.CAN-13-0308. Epub 2013 Jul 1.
6
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity.DPYD、TYMS、CDA 和 MTHFR 基因中的药物遗传学变异是氟嘧啶类毒性的临床显著预测因子。
Br J Cancer. 2013 Jun 25;108(12):2505-15. doi: 10.1038/bjc.2013.262. Epub 2013 Jun 4.
7
Tissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classification.肝细胞癌的组织代谢组学：肿瘤能量代谢和转录组分类的作用。
Hepatology. 2013 Jul;58(1):229-38. doi: 10.1002/hep.26350. Epub 2013 May 8.
8
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.欧洲肝脏研究学会-欧洲肿瘤内科学会临床实践指南：肝细胞癌的管理
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
9
Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis.细胞质磷脂酶 A2 和溶脂磷脂在肿瘤血管生成中的作用。
J Natl Cancer Inst. 2010 Sep 22;102(18):1398-412. doi: 10.1093/jnci/djq290. Epub 2010 Aug 20.
10
Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis.基于1H核磁共振的代谢组学在人类肝细胞癌和肝硬化代谢谱研究中的应用。
Cancer Sci. 2009 Apr;100(4):782-5. doi: 10.1111/j.1349-7006.2009.01086.x.

The Quest for Relevant Hepatocellular Carcinoma Biomarkers.

作者信息

Kim Jin U, Cox I Jane, Taylor-Robinson Simon D

机构信息

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Institute of Hepatology London, Foundation for Liver Research, London, United Kingdom.

出版信息

Cell Mol Gastroenterol Hepatol. 2017 Jul 14;4(2):283-284. doi: 10.1016/j.jcmgh.2017.06.003. eCollection 2017 Sep.

DOI:10.1016/j.jcmgh.2017.06.003
PMID:28795124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5540696/
Abstract
摘要